# Intravenous Remifentanil Patient-controlled Analgesia (PCA) and Epidural Patient Controlled Epidural Analgesia (PCEA) for Labor Analgesia

> **NCT00801047** · PHASE4 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 50 (actual)

## Conditions studied

- Labor
- Pain

## Interventions

- **DRUG:** Bupivacaine epidural
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT00801047
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801047, "Intravenous Remifentanil Patient-controlled Analgesia (PCA) and Epidural Patient Controlled Epidural Analgesia (PCEA) for Labor Analgesia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00801047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
